Efficacy and safety of the hypoxia-activated prodrug TH-302 in combination with gemcitabine and nab-paclitaxel in human tumor xenograft models of pancreatic cancerJessica D. Sun, Charles P. Hart, Fanying Meng et al.|Cancer Biology & Therapy|2015Cited by 51
Combination treatment with hypoxia-activated prodrug evofosfamide (TH-302) and mTOR inhibitors results in enhanced antitumor efficacy in preclinical renal cell carcinoma models.Jessica D. Sun, Charles P. Hart, Dharmendra Ahluwalia et al.|PubMed|2015Cited by 27
In vitro and in vivo antimalarial activity and chemical profiling of sugarcane leavesJude E. Okokon, Wen‐Wu Li|Scientific Reports|2022Cited by 19